Bakesiima, RitahByakika-Kibwika, PaulineTumwine, James K.Kalyango, Joan N.Nabaasa, GloriaNajjingo, IreneNabaggala, Grace S.Olweny, FrancisKaramagi, Charles2022-01-122022-01-122018Bakesiima R, Byakika- Kibwika P, Tumwine JK, et al. Dyslipidaemias in women using hormonal contraceptives: a cross sectional study in Mulago Hospital Family Planning Clinic, Kampala, Uganda. BMJ Open 2018;8:e022338. doi:10.1136/ bmjopen-2018-02233810.1136/ bmjopen-2018-022338https://nru.uncst.go.ug/xmlui/handle/123456789/1213To determine the prevalence and factors associated with dyslipidaemias in women using hormonal contraceptives. Design Cross-sectional study Setting Mulago Hospital, Kampala, Uganda Participants Three hundred and eighty-four consenting women, aged 18–49 years, who had used hormonal contraceptives for at least 3 months prior to the study. Study outcome Dyslipidaemias (defined as derangements in lipid profile levels which included total cholesterol ≥200 mg/dL, high density lipoprotein <40 mg/ dL, triglyceride >150 mg/dL or low-density lipoprotein ≥160 mg/dL) for which the prevalence and associated factors were obtained.enDyslipidaemiasWomenHormonal contraceptivesMulago Hospital Family Planning ClinicUgandaArticle